AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease.
Founded in Queensbury in 1988, AngioDynamics and has grown into a NASDAQ-listed public company. Having distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, AngioDynamics sells its products in the U.S. through a direct sales force, and in international markets through a combination of direct sales and distributors.
Investor & Technology Day 2021
IRE: Irreversible Electroporation
Vascular Access & Devices
The information in these videos is based on management estimates and industry sources as of July 2021, is not a guarantee of future performance, and is subject to risks and uncertainties, including, without limitation, FDA clearance. Viewers are cautioned that actual events or results may differ from AngioDynamics’ expectations. AngioDynamics does not assume any obligation to publicly update or revise any information in these videos for any reason.
Data Provided by Refinitiv. Minimum 15 minutes delayed.